Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Quarterly Results
Shukra Pharmaceuticals Ltd
    Industry   : Pharmaceuticals - Indian - Formulations  Chairman  : Dakshesh Shah
    Home        : Indian Private  Book Value: 1.2397304
    BSE Code  : 524632  Market Cap: 831.97
    NSE Code  :   P / E              : 100 

Change Company :
   Quarters: 
(Rs in Cr.)
Quarterly Results
ParticularsDec 2024Sep 2024Jun 2024Mar 2024
Type3Qtr2Qtr1Qtr4Qtr
Net Sales10.585.563.1810.88
Other Income1.011.020.721.38
Total Income11.596.573.9012.26
Total Expenditure 6.654.892.376.45
Operating Profit4.941.681.525.81
Interest0.150.110.060.07
Gross Profit4.791.571.465.74
Depreciation0.700.700.670.52
Tax0.890.290.271.26
Deferred Tax0.040.050.05-0.02
Reported Profit After Tax3.160.540.493.99
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter   |   Investor Complaints   |   Smart ODR   |   Attention Investors   |

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView